Cargando…
Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its’ effectiveness with botulinum toxin injection
OBJECTIVES: To compare the effects and histopathological changes of botulinum neurotoxin type A and lysozyme gene injections into prostate tissue within a testosterone induced benign prostate hyperplasia rat model. MATERIALS AND METHODS: 40 male Wistar rats were randomized into four Groups. Group-1:...
Autores principales: | Ergün, Osman, Koşar, Pinar Aslan, Onaran, İbrahim, Darici, Hakan, Koşar, Alim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734082/ https://www.ncbi.nlm.nih.gov/pubmed/28727388 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0677 |
Ejemplares similares
-
Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia
por: SANCER, Okan, et al.
Publicado: (2022) -
Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018) -
Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009) -
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Intraprostatic Botulinum Toxin injection in patients
with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009)